Toronto Dominion Bank’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-951
Closed -$62.2K 2179
2025
Q3
$62.2K Buy
+951
New +$46.4K ﹤0.01% 1569
2023
Q1
Sell
-30,706
Closed -$1.16M 1581
2022
Q4
$1.16M Sell
30,706
-600
-2% -$25.2K ﹤0.01% 1014
2022
Q3
$1.38M Buy
+31,306
New +$1.32M ﹤0.01% 1000
2021
Q2
Sell
-17,977
Closed -$808K 1431
2021
Q1
$808K Sell
17,977
-7,009
-28% -$391K ﹤0.01% 919
2020
Q4
$1.41M Buy
24,986
+2,835
+13% +$141K ﹤0.01% 857
2020
Q3
$1.05M Buy
22,151
+1,805
+9% +$100K ﹤0.01% 836
2020
Q2
$1.2M Buy
20,346
+2,111
+12% +$117K ﹤0.01% 800
2020
Q1
$863K Sell
18,235
-5,134
-22% -$286K ﹤0.01% 782
2019
Q4
$1.41M Buy
23,369
+1,949
+9% +$116K ﹤0.01% 833
2019
Q3
$1.28M Sell
21,420
-19,626
-48% -$1.28M ﹤0.01% 920
2019
Q2
$1.32M Buy
41,046
+40,999
+87,232% +$2.9M ﹤0.01% 914
2019
Q1
$4K Buy
47
+42
+840% +$2.71K ﹤0.01% 1400
2018
Q4
$0 Buy
+5
New +$255 ﹤0.01% 1569
2016
Q3
Sell
-663
Closed -$15K 1225
2016
Q2
$15K Buy
663
+4
+0.6% +$129 ﹤0.01% 1098
2016
Q1
$27K Buy
+659
New +$26.8K ﹤0.01% 1028

Other funds holding IONS

Toronto Dominion Bank's IONS Position: Q4 2025 in Review

Toronto Dominion Bank sold out of Ionis Pharmaceuticals (IONS) in Q4 2025, closing a stake of 951 shares — an estimated $62.2K sold.

Toronto Dominion Bank first reported a position in IONS in Q1 2016 and held it in 15 quarters. The position peaked at $1.41M in Q4 2020. 491 funds tracked by Wall St. Rank hold IONS as of Q4 2025.

  • Toronto Dominion Bank reported no remaining Ionis Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 951 Ionis Pharmaceuticals shares in Q4 2025, an estimated $62.2K.
  • Toronto Dominion Bank first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 15 quarters.
  • Toronto Dominion Bank's Ionis Pharmaceuticals position peaked at $1.41M in Q4 2020.
  • 491 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2025.

Based on Toronto Dominion Bank's 13F filing for Q4 2025, filed 17 Feb 2026.